|Title||CRISPR Library Screening in Cultured Cardiomyocytes.|
|Publication Type||Journal Article|
|Year of Publication||2022|
|Authors||S DeLuca, and N Bursac|
|Journal||Methods in Molecular Biology (Clifton, N.J.)|
|Pagination||1 - 13|
CRISPR-Cas9-based screening technologies enable precise, high-throughput genetic and epigenetic manipulation to study mechanisms of development and disease and identify new therapeutic targets. Here, we describe a general protocol for the generation of custom, pooled CRISPR sgRNA libraries for screening in cardiomyocyte cultures. This methodology can address a variety of lab-specific research questions in cardiomyocytes and other cell types, as the genes to be modified can be curated or whole genomes can be investigated. The use of lentiviral sgRNA delivery followed by high-throughput sequencing allows for rapid comparison and identification of candidate genes and epigenetic modifiers, which can be further validated individually or in sub-pooled libraries following screening.
|Short Title||Methods in Molecular Biology (Clifton, N.J.)|